Press-release for stocks

Prices are updated after-hours

crawled time : 18:00

save search

Agile Therapeutics Announces 1-For-40 Reverse Stock Split
Published: 2022-04-26 (Crawled : 18:00) - globenewswire.com
AGRX | $0.37 0.6% 0.0% 15K

Health Technology

| 172.66% | O: 5161.61% H: 0.0% C: -37.31%
therapeutics

Precision BioSciences Promotes Naresh Tanna to Vice President of Investor Relations
Published: 2024-02-13 (Crawled : 18:00) - biospace.com/
DTIL | $10.72 -6.86% -6.87% 70K

Health Technology

| 2757.9% | O: 2931.19% H: 0.0% C: -1.74%
precision

GWG Holdings, Inc., et al files Plan and Disclosure Statement
Published: 2022-12-09 (Crawled : 18:00) - globenewswire.com
GWGHQ | $0.011 32627.27% 100

n/a

| -89.01% | O: 1898.0% H: 0.0% C: 0.0%

Creative Medical Technology Announces Positive Top-Line Results for Type 2 Diabetes Study
Published: 2023-04-12 (Crawled : 18:00) - biospace.com/
CELZ | $4.81 -3.7% -1.73% 14K

| 7.44% | O: 160.33% H: 5.56% C: -30.56%
positive medical technology diabetes results study

LIXTE Biotechnology Announces $5.8 Million Registered Direct Offering Priced At-The-Market
Published: 2022-04-12 (Crawled : 18:00) - globenewswire.com
LIXT | $3.351 0.63% 4.68% 18K

Health Technology

| 204.55% | O: 127.27% H: 98.0% C: -26.4%
offering

PaxMedica's Research on Low Dose Suramin for Autism Spectrum Disorder Accepted for Publication
Published: 2023-10-26 (Crawled : 18:00) - globenewswire.com
PXMD | $0.7631 -4.6% -2.76% 710K

Health Technology

| -74.08% | O: 88.46% H: 16.12% C: -32.64%
publication research

Todays' Top-5
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Published: 2024-04-18 (Crawled : 18:00) - globenewswire.com
BPTH | News | $4.2 29.63% 23.94% 83M

Health Technology

| 34.19% | O: 72.84% H: 41.77% C: -22.37%
nasdaq million direct offering

GSK and SCYNEXIS Announce an Exclusive Agreement to Commercialise and Further Develop Brexafemme (ibrexafungerp), a Novel, First-in-Class Medicine to Treat Fungal Infection
Published: 2023-03-30 (Crawled : 18:00) - biospace.com/
GSK | $39.27 -0.83% 0.26% 1.9M

Health Technology

| 12.95% | O: 0.0% H: 0.65% C: 0.6%
SPRO | $1.47 -2.0% -1.35% 240K

Health Technology

| 3.45% | O: 2.07% H: 0.0% C: -2.7%
SCYX | $1.405 -1.06% 3.4% 80K

Health Technology

| -14.97% | O: 71.86% H: 3.48% C: 2.44%
infection agreement brexafemme fungal infection

Acer Therapeutics Reacquires Worldwide Development, Commercialization and Economic Rights to OLPRUVA™ from Relief Therapeutics, Excluding the Geographical Europe
Published: 2023-08-31 (Crawled : 18:00) - acertx.com
ACER | $0.9 -3.61% 420K

Health Technology

| 47.54% | O: 70.49% H: 0.0% C: 0.0%
europe worldwide commercialization therapeutics

Enveric Biosciences Signs Definitive Agreement to Acquire Exclusive License for Novel Molecules from Diverse Biotech
Published: 2021-03-10 (Crawled : 18:00) - biospace.com/
ENVB | $0.938 6.35% 3.08% 88K

Health Technology

| -68.91% | O: 70.31% H: 40.28% C: -9.02%
biotech license iot bioscience

Preliminary Data Shows that Arbutus’ Capsid Inhibitor, AB-836 is Generally Safe and Well-Tolerated and Provides Robust Antiviral Activity
Published: 2021-12-01 (Crawled : 18:00) - globenewswire.com
ABUS | News | $2.73 -1.8% -1.83% 1M

Health Technology

| -14.06% | O: 60.94% H: 26.21% C: -10.49%
antiviral

RAPT Therapeutics Reports Positive Topline Results from Phase 1b Trial of RPT193 Monotherapy in Atopic Dermatitis
Published: 2021-06-14 (Crawled : 18:00) - biospace.com/
RAPT | $7.93 -1.37% -1.26% 630K

Health Technology

| -56.7% | O: 56.92% H: 44.1% C: 37.34%
phase 1 positive therapy results dermatitis topline trial atopic dermatitis phase 1b phase 2b

RocketFuel Blockchain Confirms no Exposure to Silicon Valley Bank or Silvergate Bank
Published: 2023-03-13 (Crawled : 18:00) - globenewswire.com
RKFL | $0.0221 -12.65% 295.26% 0

Information

| -75.03% | O: 49.44% H: 0.0% C: -33.17%
blockchain

Nature's Fury Beverages Set To Land in Major Retail Locations Amidst Company Expansion and Growth
Published: 2022-05-02 (Crawled : 18:00) - prnewswire.com
EARI | $0.0002 0.0% 16M

| -99.68% | O: 46.77% H: 0.0% C: -3.3%
expansion set retail growth

Microbot Medical Announces Closing of $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
Published: 2023-05-23 (Crawled : 18:00) - globenewswire.com
MBOT | $0.89 -1.11% -2.27% 200K

Health Technology

| -51.87% | O: 44.92% H: 28.04% C: -19.19%
nasdaq direct offering medical

NanoVibronix Cites Positive Results from Independent Testing of UroShield
Published: 2023-08-30 (Crawled : 18:00) - biospace.com/
NAOV 4 | $0.75 0.61% 3.5K

Health Technology

| -48.28% | O: 44.83% H: 101.43% C: 15.71%
positive results uroshield

MRI Data Reinforce Potential of Clene’s Nanocrystal Therapy in MS
Published: 2023-02-13 (Crawled : 18:00) - biospace.com/
CLNN S | $0.3299 -2.86% -3.69% 1.2M